Use of antiepileptic drugs in the presence of liver and kidney diseases: a review.
D000927:Anticonvulsants / Q000378:metabolism* / Q000627:therapeutic use; D002220:Carbamazepine / Q000378:metabolism; D004827:Epilepsy / Q000188:drug therapy; D006207:Half-Life; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism*; D007700:Kinetics; D008107:Liver Diseases / Q000378:metabolism*; D010634:Phenobarbital / Q000378:metabolism; D010672:Phenytoin / Q000378:metabolism; D014635:Valproic Acid / Q000378:metabolism
D000927:Anticonvulsants; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin; D010634:Phenobarbital